Mirae Asset Global Investments’s Tenaya Therapeutics TNYA Stock Holding History

Mirae Asset Global Investments’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.17K	Sell	9,705 -1,601	-14%	-$1.22K	﹤0.01%	1604
2026 Q1	$7.83K	Buy	11,306 +3,215	+40%	+$2.37K	﹤0.01%	1516
2025 Q4	$5.76K	Buy	+8,091	New	+$11K	﹤0.01%	1625
2023 Q4	–	Sell	-24,002	Closed	-$61.2K	–	2600
2023 Q3	$61.2K	Hold	24,002	–	–	﹤0.01%	2534
2023 Q2	$141K	Buy	+24,002	New	+$139K	﹤0.01%	2435
2022 Q4	–	Sell	-12,808	Closed	-$37K	–	2603
2022 Q3	$37K	Buy	+12,808	New	+$59.8K	﹤0.01%	2581

Other funds holding TNYA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

RBI

Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIP

Almanack Investment Partners Wayne, Pennsylvania $785M AUM 34.37% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

R Squared Central, Hong Kong $190M AUM 25.89% 1-Year Est. Return

Mirae Asset Global Investments's TNYA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Tenaya Therapeutics (TNYA) stake by 14% in Q2 2026, selling an estimated $1.22K and leaving 9,705 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

Mirae Asset Global Investments first reported a position in TNYA in Q3 2022 and has held it in 6 quarters since. The position peaked at $141K in Q2 2023. 38 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

Mirae Asset Global Investments held 9,705 shares of Tenaya Therapeutics worth $7.17K as of Q2 2026.
Mirae Asset Global Investments sold 1,601 Tenaya Therapeutics shares in Q2 2026, an estimated $1.22K.
Tenaya Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1604 holding.
Mirae Asset Global Investments first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 6 quarters since.
Mirae Asset Global Investments's Tenaya Therapeutics position peaked at $141K in Q2 2023.
38 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.